Buy buy bispecific antibodies

@article{Holmes2011BuyBB,
  title={Buy buy bispecific antibodies},
  author={David Holmes},
  journal={Nature Reviews Drug Discovery},
  year={2011},
  volume={10},
  pages={798-800}
}
“Antibodies, in general, are extremely hot in the world of drug development right now, and bispecifics are the hottest,” says Ali Tehrani, CEO of the biotechnology company Zymeworks. His company recently put pen to paper on a partnership deal with Merck & Co. that could net Zymeworks up to US$187 million in milestone payments for using its Azymetric… CONTINUE READING